TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 2 | 1 | -22 | 30 | 41 | -34 | 3 |
| P | %wins | 100 | 50 | 0 | 50 | 50 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/12 16:34 | 5/4/12 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 11 LP | MD | T | P.d | 22,000 | 5.00 | 1 | 4,400 | 70 | 10,641 | D | 11 | 0 | -2 | -30 | 80 | 91 | -24 | ||||||||
3/9/12 15:55 | 3/7/12 | FOLD | Amicus Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 11 LP | MD | T | P | 5,273 | 5.70 | 1 | 925 | 25 | 4,584 | D | 68 | -5 | 40 | 63 | -14 | -15 | -7 | -2 | 3 | 4 | -13 | -20 | -9 | -44 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |